Skip to content

Plasticizers and in Vitro Fertilization Outcomes

To Investigate the Effect of Plasticizers on the Pregnancy in Vitro Fertilization Cycles

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03733912
Enrollment
80
Registered
2018-11-07
Start date
2018-07-11
Completion date
2020-12-31
Last updated
2021-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertilization in Vitro

Brief summary

To investigate the effect of Plasticizer metabolites concentration on the in vitro fertilization outcomes

Detailed description

This study was conducted in a medical center in southern Taiwan. 80 infertile female patients, aged 30 to 40 years old with normal ovarian function, receiving IVF treatment in the infertility outpatient were enrolled in this study. The participates were divided into two groups: successful pregnancy in the IVF cycle (n = 40) and non-pregnancy in the IVF cycle (n = 40). After getting the consent of the patients, we plan to do a questionnaire survey. Additionally, environmental dust and urine were sampled and analyzed the concentration of plasticizers metabolites.The aim of this study is to investigate the effect of Plasticizer metabolites concentration on the in vitro fertilization outcomes.

Interventions

OTHERPhthalate metabolites measurement

To measure phthalate metabolites of urine and house dust in Pregnancy and Non-pregnancy groups

Sponsors

Kaohsiung Veterans General Hospital.
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Infertile women undergoing in vitro fertilization cycles * Normal ovarian reserve (AMH \> 1.0 and AFC ≧ 5)

Exclusion criteria

* Daily homestay time \> 12 hrs * Diminished ovarian reserve (AMH ≦ 1.0 or AFC\<5) * Oophorectomy * Gynecologic cancer patients * Severe male infertility

Design outcomes

Primary

MeasureTime frameDescription
Phthalate of urinethrough study completion, an average of 1 yearPhthalate metabolites concentrations

Secondary

MeasureTime frameDescription
Phthalate of environmental dustthrough study completion, an average of 1 yearPhthalate metabolites concentrations

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026